Aktan AO, Yalin R (1996) Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur J Gastroenterol Hepatol 8(9):877–879
Ammann RW, Eckert J (1996) Cestodes. Echinococcus. Gastroenterol Clin N Am 25:655–689
Baimas-George M, Thompson KJ, Watson MD, Iannitti DA, Martinie JB, Baker EH, Levi D, Vrochides D (2021) The technical aspects of ex vivo hepatectomy with autotransplantation: a systematic review and meta-analysis. Langenbeck’s Arch Surg 406(7):2177–2200
Bellanger AP, Courquet S, Pallandre JR, Godet Y, Millon L (2020) Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitro. Parasite Immunol 42(6):e12711
Bresson-Hadni S, Vuitton DA, Bartholomot B, Heyd B, Godart D, Meyer JP et al (2000) A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 12:327–336
Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E et al (2011) Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl 17:855–865
Brunetti E, Kern P, Vuitton DA (2010) Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 114:1–16
Buttenschoen K, Gruener B, Carli Buttenschoen D, Reuter S, Henne-Bruns D, Kern P (2009) Palliative operation for the treatment of alveolar echinococcosis. Langenbeck’s Arch Surg 394(1):199–204
Chai JY, Jung BK, Hong SJ (2021) Albendazole and Mebendazole as antiparasitic and anti-cancer agents: an update. Korean J Parasitol 59(3):189–225
Colley DG, Sasser LE, Reed AM (2005) PD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity. Parasite Immunol 27:45–53
Dervenis C, Delis S, Avgerinos C, Madariaga J, Milicevic M (2005) Changing concepts in the management of liver hydatid disease. J Gastrointestinal Surg 9(6):869–877
Egan TJ, Ross DC, Adams PA (1994) Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett 352(1):54–57
Enkai S, Inaoka DK, Kouguchi H, Irie T, Yagi K, Kita K (2020) Mitochondrial complex III in larval stage of Echinococcus multilocularis as a potential chemotherapeutic target and in vivo efficacy of atovaquone against primary hydatid cysts. Parasitol Int 75:102004
Ghosh Dastidar D, Saha S, Chowdhury M (2018) Porous microspheres: synthesis, characterisation and applications in pharmaceutical & medical fields. Int J Pharm 548(1):34–48
Giorgio A, de Stefano G, Esposito V, Liorre G, Di Sarno A, Giorgio V et al (2008) Long-term results of percutaneous treatment of hydatid liver cysts: a single center 17 years experience. Infect 36(3):256–261
Giorgio A, Di Sarno A, De Stefano G et al (2009) Percutaneous treatment of hydatid liver cyst. Recent Pat Antiinfect Drug Discov 4(1):29–36
Guo Z, Duo H, Zhang X, Ma Y, Shen X, Fu Y (2021) A pilot study on deworming wild foxes for Echinococcus spp. in Qinghai, China. Iran J Parasitol 16(4):672–677
Hemphill A, Stadelmann B, Rufener R et al (2014) Treatment of echinococcosis: albendazole and mebendazole – what else? Parasite 21:70
Hernández A, O’Connor JE, Mir A (1999) Phenotypic analysis of peripheral lymphocyte subpopulations in hydatid patients. Parasitol Res 85(11):948–950
Huang X, Wiehr S, Wild AM, Voßberg P, Hoffmann W, Grüner B, Köhler C, Soboslay PT (2018) The effects of taxanes, vorinostat and doxorubicin on growth and proliferation of Echinococcus multilocularis metacestodes assessed with magnetic resonance imaging and simultaneous positron emission tomography. Oncotarget 9(10):9073–9087
Ishizu H, Uchino J, Sato N, Aoki S, Suzuki K, Kuribayashi H (1997) Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology 25:528–531
Jebbawi F, Bellanger AP, Lunström-Stadelmann B, Rufener R, Dosch M, Goepfert C, Gottstein B, Millon L, Grandgirard D, Leib SL, Beldi G, Wang J (2021) Innate and adaptive immune responses following PD-L1 blockade in treating chronic murine alveolar echinococcosis. Parasite Immunol 43(8):e12834
Jie HB, Gildener-Leapman N, Li J, Srivastava RM, Gibson SP et al (2013) Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. Br J Cancer 109:2629–2635
Kabaalioğlu A, Çeken K, Alimoglu E, Apaydin A (2006) Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice? Eur J Radiol 59(1):65–73
Kahriman G, Ozcan N, Dogan S, Karaborklu O (2017) Percutaneous treatment of liver hydatid cysts in 190 patients: a retrospective study. Acta Radiol 58(6):676–684
Kamiyama T (2020) Recent advances in surgical strategies for alveolar echinococcosis of the liver. Surg Today 50(11):1360–1367
Kern P, Menezes da Silva A, Akhan O, Mullhaupt B, Vizcaychipi KA, Budke C, Vuitton DA (2017) The echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol 96:259–369
Küster T, Kriegel N, Stadelmann B, Wang X, Dong Y, Vennerstrom JL, Keiser J, Hemphill A (2014) Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes. Int J Antimicrob Agents 43:40–46
Küster T, Stadelmann B, Rufener R, Risch C, Müller J, Hemphill A (2015) Oral treatments of Echinococcus multilocularis-infected mice with the anti-malarial drug mefloquine that potentially interacts with parasite ferritin and cystatin. Int J Antimicrob Agents 46(5):546–551
La X, Zhang F, Li Y et al (2015) Upregulation of PD-1 on CD4+CD25+ T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis. Int Immunopharmacol 26(2):357–366
Lee Y, Thompson DH (2017) Stimuli-responsive liposomes for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(5). https://doi.org/10.1002/wnan.1450
Lepenies B, Jacobs T (2008) The role of negative costimulators during parasitic infections. Endocr Metab Immune Disord Drug Targets 8:279–288
Liu C, Zhang H, Yin J, Hu W (2015) In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis. Parasitol Res 114(6):2213–2222
Liu C, Yin J, Xue J, Tao Y, Hu W, Zhang H (2018) In vitro effects of amino alcohols on echinococcus granulosus. Acta Trop 182:285–290
McManus DP, Gray DJ, Zhang W, Yang Y (2012) Diagnosis, treatment, and management of echinococcosis. BMJ 344:e3866
Nair AR, Lakshman YD, Anand VSK, Sree KSN, Bhat K, Dengale SJ (2020) Overview of extensively employed polymeric carriers in solid dispersion technology. AAPS PharmSciTech 21(8):309
Naseri M, Akbarzadeh A, Spotin A, Akbari NA, Mahami-Oskouei M, Ahmadpour E (2016) Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces. Parasitol Res 115(12):4595–4603
Nicolao MC, Elissondo MC, Denegri GM, Goya AB, Cumino AC (2014) In vitro and in vivo effects of tamoxifen against larval stage Echinococcus granulosus. Antimicrob Agents Chemother 58(9):5146–5154
Nicolao MC, Loos JA, Rodriguez Rodrigues C, Beas V, Cumino AC (2017) Bortezomib initiates endoplasmic reticulum stress, elicits autophagy and death in Echinococcus granulosus larval stage. PLoS One 12(8):e0181528
Pan W, Xu HW, Hao WT et al (2018) The excretory-secretory products of Echinococcus granulosus protoscoleces stimulated IL-10 production in B cells via TLR-2 signaling. BMC Immunol 19(1):29
Pang N, Zhang F, Ma X, Zhang Z, Zhao H et al (2014) Th9/IL-9 profile in human echinococcosis: their involvement in immune response during infection by echinococcus granulosus. Mediat Inflamm 2014:781649
Panwar P, Pandey B, Lakhera PC, Singh KP (2010) Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine 5:101–108
Papaconstantinou I, Kontos M, Prassas E et al (2006) Radio frequency ablation (RFA)-assisted pericystectomy for hepatic echinococcosis: an alternative technique. Surg Laparosc Endosc Percutan Tech 16(5):338–341
Paternoster G, Boo G, Wang C et al (2020) Epidemic cystic and alveolar echinococcosis in Kyrgyzstan: an analysis of national surveillance data. Lancet Glob Health 8(4):e603–e611
Pensel PE, Albani C, Gamboa GU, Benoit JP, Elissondo MC (2014) In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells. Acta Trop 140:1–9
Pittini A, Martı’nez-Acosta YE, Casaravilla C, Seoane PI, Ruckerl D, Quijano C et al (2019) Particles from the Echinococcus granulosus laminated layer inhibit CD40 upregulation in dendritic cells by interfering with Akt activation. Infect Immun 87:e00641–e00619
Qin W, Guan D, Ma R, Yang R, Xing G, Shi H, Tang G, Li J, Lv H, Jiang Y (2017) Effects of trigonelline inhibition of the Nrf2 transcription factor in vitro on Echinococcus granulosus. Acta Biochim Biophys Sin Shanghai 49(8):696–705
Ramia JM (2012) Ambispective comparative study of two surgical strategies for liver hydatidosis. World J Gastroenterol 18(6):546
Rufener R, Ritler D, Zielinski J, Dick L, da Silva ET, da Silva AA, Joekel DE, Czock D, Goepfert C, Moraes AM, de Souza MVN, Müller J, Mevissen M, Hemphill A, Lundström-Stadelmann B (2018) Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis. Int J Parasitol Drugs Drug Resist 8(2):331–340
Sato N, Namieno T, Furuya K, Takahashi H, Yamashita K, Uchino J et al (1997) Contribution of mass screening system to resectability of hepatic lesions involving Echinococcus multilocularis. J Gastroenterol 32:351–354
Shiee MR, Kia EB, Zahabiun F et al (2021) In vitro effects of tropisetron and granisetron against Echinococcus granulosus (s.s.) protoscoleces by involvement of calcineurin and calmodulin. Parasit Vectors 14(1):197
Smego RA, Sebanego P (2005) Treatment options for hepatic cystic echinococcosis. Int J Infect Dis 9(2):69–76
Stadelmann B, Rufener R, Aeschbacher D, Spiliotis M, Gottstein B, Hemphill A (2016) Screening of the open source malaria box reveals an early lead compound for the treatment of alveolar echinococcosis. PLoS Negl Trop Dis 10:e0004535
Stojkovic M, Zwahlen M, Teggi A et al (2009) Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis 3(9):524
Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW et al (2008) Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 49:72–77
Wang J, Gottstein B (2016) Immunoregulation in larval Echinococcus multilocularis infection. Parasite Immunol 38:182–192
Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP (2019) Echinococcosis: advances in the 21st century. Clin Microbiol Rev 32(2):e00075–e00018
Wilde B, Hua F, Dolff S, Jun C, Cai X et al (2012) Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis. Rheumatology (Oxford) 51:1188–1197
Yan J, Deng M, Kong S et al (2022) Transarterial chemoembolization in combination with programmed death-1/programmed cell death-ligand 1 immunotherapy for hepatocellular carcinoma: a mini review. iliver 1(4):225–234
Yuan M, Luo Y, Xin Q, Gao H, Zhang G, Jing T (2016) Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo. Vet Parasitol 226:38–43
Zacharoulis D, Poultsidis A, Roundas C et al (2006) Liver hydatid disease: radiofrequency-assisted pericystectomy. Ann R Coll Surg Engl 88(5):499–500
Zawistowski M, Nowaczyk J, Jakubczyk M, Domagała P (2020) Outcomes of ex vivo liver resection and autotransplantation: a systematic review and meta-analysis. Surgery 168(4):631–642
Zerem E, Jusufovic R (2006) Percutaneous treatment of univesicular versus multivesicular hepatic hydatid cysts. Surg Endosc 20(10):1543–1547